Emily J. Park

Emily J. Park

Auto-generated profile, based on publicly available information

Emily J. Park

Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, Texas 77030, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Cell Stem Cell
Verified
Journal Article
Closed access
MRMarkus Riessland
Markus Riessland
BKBenjamin Kolisnyk
Benjamin Kolisnyk
TKTae Wan Kim
Tae Wan Kim
JCJia Cheng
Jia Cheng
JNJason Ni
Jason Ni
PGPaul Greengard
Paul Greengard

1 February 2024 in Aging Cell
Verified
Journal Article
Open access
TRTaylor Russo
Taylor Russo
BKBenjamin Kolisnyk
Benjamin Kolisnyk
ASAswathy B. S.
Aswathy B. S.
JPJonathan Plessis‐Belair
Jonathan Plessis‐Belair
TKTae Wan Kim
Tae Wan Kim
Markus RiesslandMarkus Riessland
Markus Riessland
Idiopathic Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, which is associated with neuroinflammation and reactive gliosis. The underlying cause of PD and the concurrent neuroinflammation are not well understood. In this study, we utilize human and murine neuronal lines, stem cell‐derived dopaminergic neurons, and mice to demonstrate that three previously identified genetic risk factors for PD, namely SATB1, MIR22HG, and GBA, are components of a single gene regulatory pathway. Our findings indicate that dysregulation of this pathway leads to the upregulation of glucocerebrosides (GluCer), which triggers a cellular senescence‐like phenotype in dopaminergic neurons. Specifically, we discovered that downregulation of the transcriptional repressor SATB1 results in the derepression of the microRNA miR‐22‐3p, leading to decreased GBA expression and subsequent accumulation of GluCer. Furthermore, our results demonstrate that an increase in GluCer alone is sufficient to impair lysosomal and mitochondrial function, thereby inducing cellular senescence. Dysregulation of the SATB1‐MIR22‐GBA pathway, observed in both PD patients and normal aging, leads to lysosomal and mitochondrial dysfunction due to the GluCer accumulation, ultimately resulting in a cellular senescence‐like phenotype in dopaminergic neurons. Therefore, our study highlights a novel pathway involving three genetic risk factors for PD and provides a potential mechanism for the senescence‐induced neuroinflammation and reactive gliosis observed in both PD and normal aging.

28 October 2025 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
PPPatrizia Pessina
Patrizia Pessina
MNMika Nevo
Mika Nevo
JSJunchao Shi
Junchao Shi
SKSrikanth Kodali
Srikanth Kodali
ECEduard Casas
Eduard Casas
BSBruno Di Stefano
Bruno Di Stefano
Controlling stem cell differentiation is a longstanding goal in biomedical research. Here we explore how cell fate is influenced by RNA condensates, specifically P-bodies, which modulate gene expression posttranscriptionally. We profiled the transcriptomes of biomolecular condensates in diverse developmental contexts spanning multiple vertebrate species. Our analyses revealed conserved, cell type-specific sequestration of untranslated RNAs encoding cell fate regulators. P-body RNA contents do not reflect active gene expression in each cell type but are enriched for translationally repressed transcripts characteristic of the preceding developmental stage. Mechanistically, P-body contents are controlled by microRNAs and can be profoundly reshaped by perturbing AGO2 or polyadenylation site usage. Applying these insights to stem cell differentiation, we show that manipulating P-body assembly or microRNA activity can direct naive mouse and human pluripotent stem cells toward totipotency or primed human embryonic cells toward the germ cell lineage. Our findings link cell fate decisions to RNA condensates across vertebrates and provide a means of controlling cell identity.

1 August 2018 in Current Biology
Verified
Journal Article
Closed access
EPEmily J. Park
Emily J. Park
SWSara M. Wasserman
Sara M. Wasserman

21 July 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
TRTaylor Russo
Taylor Russo
BKBenjamin Kolisnyk
Benjamin Kolisnyk
ABAswathy Bs
Aswathy Bs
TKTae Wan Kim
Tae Wan Kim
JMJacqueline Martin
Jacqueline Martin
Markus RiesslandMarkus Riessland
Markus Riessland
Idiopathic Parkinson’s Disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, which is associated with neuroinflammation and reactive gliosis. The underlying cause of PD and the concurrent neuroinflammation are not well understood. In this study, we utilized human and murine neuronal lines, stem cell–derived dopaminergic neurons, and mice to demonstrate that three previously identified genetic risk factors for PD, namely SATB1, MIR22HG, and GBA, are components of a single gene regulatory pathway. Our findings indicate that dysregulation of this pathway leads to the upregulation of glucocerebrosides (GluCer), which triggers a cellular senescence-like phenotype in dopaminergic neurons. Specifically, we discovered that downregulation of the transcriptional repressor SATB1 results in the derepression of the microRNA miR-22-3p, leading to decreased GBA expression and subsequent accumulation of GluCer. Furthermore, our results demonstrate that an increase in GluCer alone is sufficient to impair lysosomal and mitochondrial function, thereby inducing cellular senescence dependent on S100A9 and stress factors. Dysregulation of the SATB1-MIR22-GBA pathway, observed in both PD patients and normal aging, leads to lysosomal and mitochondrial dysfunction due to the GluCer accumulation, ultimately resulting in a cellular senescence-like phenotype in dopaminergic neurons. Therefore, our study highlights a novel pathway involving three genetic risk factors for PD and provides a potential mechanism for the senescence-induced neuroinflammation and reactive gliosis observed in both PD and normal aging.

19 May 2026 in Genes & Development
Verified
Journal Article
Open access
EPEmily J. Park
Emily J. Park
FLFlorencia Levin-Ferreyra
Florencia Levin-Ferreyra
BSBruno Di Stefano
Bruno Di Stefano
Differentiation requires coordinated exit from the stem cell state, during which gene regulatory networks sustaining self-renewal are dismantled, while lineage-specific programs are activated. This transition is governed by chromatin modifications, transcriptional networks, RNA processing, translational control, and metabolic rewiring that must operate with temporal precision. Despite significant progress in identifying individual regulatory components, understanding how these layers integrate to orchestrate irreversible cell fate commitment remains a fundamental challenge. This review examines common and unique regulatory principles governing stem cell exit, from totipotency during early embryogenesis to tissue-specific stem cell differentiation in adults. We synthesize recent findings on regulatory mechanisms across mammalian species, highlight species-specific adaptations, and explore the concept of reversibility in differentiation. Elucidating these principles has broad implications for regenerative medicine, cellular reprogramming, and diseases in which differentiation programs are corrupted.